Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filedfiledCritical
Priority to ECSP951377priorityCriticalpatent/ECSP951377A/en
Publication of ECSP951377ApublicationCriticalpatent/ECSP951377A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
Se refiere a compuestos de la fórmula: donde R1, R2 y R3 se definen en la memoria descriptiva y las sales aceptables farmacéuticamente de tales compuestos. Los compuestos de la fórmula Y muestran actividad antibiótica contra una amplia gama de organismos gram-positivos y gram-negativos, incluídos organismos que son resistentes a antibióticos de tetraciclina.It refers to compounds of the formula: where R1, R2 and R3 are defined in the specification and the pharmaceutically acceptable salts of such compounds. The compounds of formula Y show antibiotic activity against a wide range of gram-positive and gram-negative organisms, including organisms that are resistant to tetracycline antibiotics.
ECSP9513771995-02-031995-02-03
ANALOGS OF DOXICICLINE
ECSP951377A
(en)
COMPOUNDS WHICH ARE DERIVATIVE FROM THE ANTIBIOTICS MACROLIDES ROSARAMYCIN, REPROMYCIN, 5-MICAMINOSYLTILONOLIDE, DESMYCO-SINE, LACTENOCINE, O-DESMETIL-LACTENOCINE, CIRRAMYCIN A1, AND 23-DEOXYMICAMINOSYLTILONOLIDE